Provides public access to epinephrine auto-injector devices at schools; establishes public access epinephrine auto-injector device providers.
Summary
This bill would expand New York’s public access epinephrine auto-injector law to cover schools and certain school-related entities. It amends the Education Law to deem school districts, boards of cooperative educational services (BOCES), county vocational education and extension boards, charter schools, and nonpublic elementary and secondary schools to be “public access epinephrine auto-injector device providers” under the Public Health Law.
The bill also adds a new definition of that provider term and imposes operational requirements on covered entities. Those requirements include maintaining and testing epinephrine auto-injector devices according to manufacturer and government standards, notifying the regional council of the device’s existence, location, and type, and posting signage at the main entrance indicating where the device is stored or maintained. The act would take effect 90 days after becoming law.
Impact
The bill would amend both the Education Law and Public Health Law, effectively bringing schools and related educational institutions into the state’s public access epinephrine framework. It would require covered schools and school entities to maintain and monitor epinephrine auto-injectors, report them to the regional council, and provide public notice of their location, creating new compliance obligations for public and nonpublic educational facilities.
Sentiment
Based on the bill’s text and the absence of recorded opposition, the measure appears to be framed as a public health and school safety initiative with a generally protective, preventive purpose. The proposal is consistent with broad support for emergency preparedness in schools and access to life-saving medication for allergic reactions. No committee transcript or vote record was provided, so there is no documented debate or formal sentiment from legislative proceedings in the materials supplied.
Contention
No specific points of contention are documented in the provided materials. Potential areas of concern, if raised in future debate, could include the administrative burden on schools, costs of purchasing and maintaining devices, training and compliance responsibilities, and how the requirements would be implemented across public, charter, and nonpublic schools. However, none of those objections appear in the supplied record.
In school health services, further providing for definitions, for possession and use of asthma inhalers and epinephrine auto-injectors, for school access to emergency epinephrine and for administration of epinephrine auto-injectors by school bus drivers and school crossing guards.
In epinephrine auto-injector entities, further providing for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.
In epinephrine auto-injector entities, further providing for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.
In school health services, further providing for definitions, for possession and use of asthma inhalers and epinephrine auto-injectors, for school access to emergency epinephrine and for administration of epinephrine auto-injectors by school bus drivers and school crossing guards.
In epinephrine auto-injector entities, further providing for scope of chapter, for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.